Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Azenta, Inc. (NASDAQ:AZTA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 54,551 shares of the company's stock, valued at approximately $1,890,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.12% of Azenta as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also added to or reduced their stakes in the company. Lord Abbett & CO. LLC purchased a new stake in shares of Azenta in the 4th quarter valued at $47,350,000. Norges Bank bought a new stake in Azenta during the 4th quarter valued at $25,403,000. Marshall Wace LLP bought a new stake in Azenta during the 4th quarter valued at $20,469,000. Conestoga Capital Advisors LLC raised its holdings in Azenta by 21.4% during the 1st quarter. Conestoga Capital Advisors LLC now owns 1,915,556 shares of the company's stock valued at $66,355,000 after buying an additional 337,675 shares during the last quarter. Finally, Federated Hermes Inc. raised its holdings in Azenta by 65.9% during the 4th quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock valued at $38,109,000 after buying an additional 302,786 shares during the last quarter. Institutional investors own 99.08% of the company's stock.
Analysts Set New Price Targets
Several brokerages have commented on AZTA. Evercore ISI upped their price objective on shares of Azenta from $29.00 to $35.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Stephens started coverage on shares of Azenta in a research note on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 price target for the company. Finally, Needham & Company LLC decreased their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th.
Get Our Latest Report on Azenta
Azenta Stock Performance
NASDAQ AZTA traded down $0.36 on Friday, hitting $32.34. 496,951 shares of the stock were exchanged, compared to its average volume of 540,877. The stock has a fifty day moving average price of $30.92 and a two-hundred day moving average price of $35.18. The firm has a market capitalization of $1.48 billion, a P/E ratio of -23.27 and a beta of 1.59. Azenta, Inc. has a 52-week low of $23.91 and a 52-week high of $60.60.
Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. Azenta's revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.06 earnings per share. Sell-side analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.
About Azenta
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Stories

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.